Victorian Antibody Initiative
Fast access to high quality novel antibodies has just become easier!
A joint initiative between the Walter and Eliza Hall Institute (WEHI), the Commonwealth Scientific and Industrial Research Organisation (CSIRO) and Monash Antibody Technologies Facility (MATF) that provides the biomedical research community with an antibody partner fully attuned to the demands of world-class science.
The Victorian Antibody Initiative (VAI) brings together the state-of-the-art automated production facilities at MATF with the premier customised development services at WEHI and CSIRO for the very best in monoclonal and polyclonal antibody production.
For more than two decades, the Walter and Eliza Hall Institute’s Antibody Facility has been integral to the institute’s leading position in biomedical research and developing pre-clinical drug candidates and has earned a reputation for providing world-class antibody development services. The personalised approach to customer service guarantees that academic and industry users return to this facility time and again for their antibody requirements.
In 2008, investment by Monash University, the Victorian State Government and the Australian Federal Government (Bioplatforms Australia) created scale through the Monash Antibody Technologies Facility, one of the most sophisticated, high-throughput monoclonal antibody facilities in the world.
In partnership, two of Australia’s leading and complementing antibody facilities can provide you with a “one stop” point of contact to access the best technology and customer service for production of your immunological tools and reagents.
The Victorian Antibody Initiative is lead by a team having exceptional experience in antibody design and production, including Kaye Wycherley and Paul Masendycz from The Walter and Eliza Hall Institute and Hayley Ramshaw from Monash University.
Contact us for further information: